Skip to main content
JAK inhibitor ivarmacitinib shows efficacy for atopic dermatitis in a pivotal trial
Primary tabs
•••
View
Get Stamp Tags
Published Locations
Breadcrumb
Home
JAK inhibitor ivarmacitinib shows efficacy for atopic dermatitis in a pivotal trial
User login
Username
Password
Reset your password
Concept
Lead
score
Dermatitis
1
1
Atopic Dermatitis
0
0.99
Pruritus
0
0.71
Eczema
0
0.24
Grant
0
0.24
Quality of Life
0
0.24
Rheumatoid Arthritis
0
0.16
Alopecia Areata
0
0.12
Arthritis
0
0.12
Canada
0
0.12
Clinical Research
0
0.12
Hospital
0
0.12
Immunology
0
0.12
New York
0
0.12
Severity Index
0
0.12
Alopecia
0
0.11
Healthcare and Medical Technology
0
0.11
Inflammatory Bowel Disease
0
0.11
Thromboembolism
0
0.11
Specialty
Lead
score
Dermatology
1
1
Allergy & Clinical Immunology
0
0.6
Family Medicine/Primary Care
0
0.9
Internal Medicine
0
0.8
Rheumatology
0
0.7
Edit Tags